Dendritic cell-endothelial cell cross-talk in angiogenesis.

[1]  S. Haffner,et al.  Differentiation of Human Tumour‐associated Dendritic Cells into Endothelial‐like Cells: An Alternative Pathway of Tumour Angiogenesis , 2007, Scandinavian journal of immunology.

[2]  H. Fujii,et al.  Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2 , 2007, Cancer Immunology, Immunotherapy.

[3]  S. Akira,et al.  Macrophages and Myeloid Dendritic Cells, but Not Plasmacytoid Dendritic Cells, Produce IL-10 in Response to MyD88- and TRIF-Dependent TLR Signals, and TLR-Independent Signals1 , 2006, The Journal of Immunology.

[4]  P. Kaye,et al.  Stromal-cell regulation of dendritic-cell differentiation and function. , 2006, Trends in immunology.

[5]  D. Ribatti,et al.  Cutting Edge: IL-1β Mediates the Proangiogenic Activity of Osteopontin-Activated Human Monocytes1 , 2006, The Journal of Immunology.

[6]  Giuseppe Leone,et al.  Tolerogenic dendritic cells: cytokine modulation comes of age. , 2006, Blood.

[7]  Hua Tang,et al.  Endothelial stroma programs hematopoietic stem cells to differentiate into regulatory dendritic cells through IL-10. , 2006, Blood.

[8]  E. Ekland,et al.  Regulation of lymph node vascular growth by dendritic cells , 2006, The Journal of experimental medicine.

[9]  P. Romeo,et al.  Dendritic Cells Can Turn CD4+ T Lymphocytes into Vascular Endothelial Growth Factor-Carrying Cells by Intercellular Neuropilin-1 Transfer1 , 2006, The Journal of Immunology.

[10]  J. Schroeder,et al.  Interleukin-10 and Th2 cytokines differentially regulate osteopontin expression in human monocytes and dendritic cells. , 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[11]  S. Ferrari,et al.  Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. , 2006, Blood.

[12]  L. Glimcher,et al.  Osteopontin expression is essential for interferon-α production by plasmacytoid dendritic cells , 2006, Nature Immunology.

[13]  M. Burdick,et al.  Cancer CXC chemokine networks and tumour angiogenesis. , 2006, European journal of cancer.

[14]  C. Garlanda,et al.  Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL‐10 and inhibition by IFN‐γ , 2006, Journal of leukocyte biology.

[15]  J. Connolly,et al.  Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. , 2006, Blood.

[16]  Richard A Flavell,et al.  Transforming growth factor-beta regulation of immune responses. , 2006, Annual review of immunology.

[17]  Marco Presta,et al.  Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey. , 2006, Endothelium : journal of endothelial cell research.

[18]  F. Bussolino,et al.  Semaphoring vascular morphogenesis. , 2006, Endothelium : journal of endothelial cell research.

[19]  R. Badolato,et al.  Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma. , 2006, Blood.

[20]  M. Young,et al.  Tumor skewing of CD34+ cell differentiation from a dendritic cell pathway into endothelial cells , 2006, Cancer Immunology, Immunotherapy.

[21]  Peter Carmeliet,et al.  Angiogenesis in life, disease and medicine , 2005, Nature.

[22]  S. Sozzani.  Dendritic cell trafficking: more than just chemokines. , 2005, Cytokine & growth factor reviews.

[23]  M. Goldman,et al.  Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells. , 2005, Blood.

[24]  S. Bernasconi,et al.  Cutting Edge: Proangiogenic Properties of Alternatively Activated Dendritic Cells1 , 2005, The Journal of Immunology.

[25]  G. Trinchieri,et al.  Production of type I interferons , 2005, The Journal of experimental medicine.

[26]  T. Ahrens,et al.  Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. , 2005, Blood.

[27]  P. Comoglio,et al.  Sema4D induces angiogenesis through Met recruitment by Plexin B1. , 2005, Blood.

[28]  G. Coukos,et al.  The role of dendritic cell precursors in tumour vasculogenesis , 2005, British Journal of Cancer.

[29]  C. Jancic,et al.  Migration of polymorphonuclear leucocytes is influenced by dendritic cells , 2005, Immunology.

[30]  G. Coukos,et al.  Vascular leukocytes contribute to tumor vascularization. , 2005, Blood.

[31]  T. Walzer,et al.  Plexin C1 Engagement on Mouse Dendritic Cells by Viral Semaphorin A39R Induces Actin Cytoskeleton Rearrangement and Inhibits Integrin-Mediated Adhesion and Chemokine-Induced Migration , 2005, The Journal of Immunology.

[32]  D. Carbone,et al.  Differential Roles of Vascular Endothelial Growth Factor Receptors 1 and 2 in Dendritic Cell Differentiation1 , 2005, The Journal of Immunology.

[33]  C. Garlanda,et al.  Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. , 2005, Annual review of immunology.

[34]  J. Cebon,et al.  Dendritic cell development , 2004 .

[35]  D. Rukavina,et al.  An Insight into the Dendritic Cells at the Maternal–Fetal Interface , 2004, American journal of reproductive immunology.

[36]  G. Trinchieri,et al.  Plasmacytoid dendritic cells in immunity , 2004, Nature Immunology.

[37]  A. Bouchard,et al.  Molecular definition of an in vitro niche for dendritic cell development. , 2004, Experimental hematology.

[38]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[39]  Hua Tang,et al.  Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells , 2004, Nature Immunology.

[40]  J. Nelson,et al.  Function and survival of dendritic cells depend on endothelin-1 and endothelin receptor autocrine loops. , 2004, Blood.

[41]  A. Böhle,et al.  Platelet factor 4 in conjunction with IL‐4 directs differentiation of human monocytes into specialized antigen‐ presenting cells , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  R. Homer,et al.  Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung , 2004, Nature Medicine.

[43]  Lin Zhang,et al.  Tumor-infiltrating dendritic cell precursors recruited by a β-defensin contribute to vasculogenesis under the influence of Vegf-A , 2004, Nature Medicine.

[44]  P. Carmeliet,et al.  Dendritic Cell Subsets Differentially Regulate Angiogenesis in Human Ovarian Cancer , 2004, Cancer Research.

[45]  M. Dana,et al.  Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity , 2004, Nature Medicine.

[46]  Barbara Bottazzi,et al.  PTX3 inhibits angiogenesis Selective recognition of fibroblast growth factor-2 by the long pentraxin , 2013 .

[47]  J. Lifson,et al.  Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic Cells , 2004, Journal of Virology.

[48]  J. Pober,et al.  T lymphocyte-endothelial cell interactions. , 2004, Annual review of immunology.

[49]  S. Rafii,et al.  Tumor Necrosis Factor Alpha‐Stimulated Endothelium: An Inducer of Dendritic Cell Development from Hematopoietic Progenitors and Myeloid Leukemic Cells , 2004, Stem cells.

[50]  P. Allavena,et al.  Infiltration of tumours by macrophages and dendritic cells: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2004, Novartis Foundation symposium.

[51]  M. Rusnati,et al.  HIV-1 Tat protein and endothelium: From protein/cell interaction to AIDS-associated pathologies , 2004, Angiogenesis.

[52]  R. Kreienberg,et al.  Angiogenesis during primate placentation in health and disease. , 2003, Reproduction.

[53]  J. Abe,et al.  Thrombospondin 1 Is an Autocrine Negative Regulator of Human Dendritic Cell Activation , 2003, The Journal of experimental medicine.

[54]  Alberto Mantovani,et al.  Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells , 2003, European journal of immunology.

[55]  A. Wong,et al.  CIITA-regulated plexin-A1 affects T-cell–dendritic cell interactions , 2003, Nature Immunology.

[56]  H. Kikutani,et al.  Immune semaphorins: a new area of semaphorin research , 2003, Journal of Cell Science.

[57]  C. Xia,et al.  Effect of CXC chemokine platelet factor 4 on differentiation and function of monocyte-derived dendritic cells. , 2003, International immunology.

[58]  D. Ribatti,et al.  Osteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis1 , 2003, The Journal of Immunology.

[59]  T. Reinhart.  Chemokine induction by HIV-1: recruitment to the cause. , 2003, Trends in immunology.

[60]  R. Steinman.  Some interfaces of dendritic cell biology , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[61]  Shahin Rafii,et al.  Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration , 2003, Nature Medicine.

[62]  A. Aderem,et al.  The Toll-Like Receptor 5 Stimulus Bacterial Flagellin Induces Maturation and Chemokine Production in Human Dendritic Cells1 , 2003, The Journal of Immunology.

[63]  G. Trinchieri,et al.  Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.

[64]  L. Adorini,et al.  Cutting Edge: Differential Chemokine Production by Myeloid and Plasmacytoid Dendritic Cells1 , 2002, The Journal of Immunology.

[65]  S. Sakoda,et al.  Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2 , 2002, Nature.

[66]  Olivier Hermine,et al.  A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response , 2002, Nature Immunology.

[67]  M. Grace,et al.  Interferon‐α as an immunotherapeutic protein , 2002, Journal of Leukocyte Biology.

[68]  Yong‐jun Liu,et al.  Mouse and human dendritic cell subtypes , 2002, Nature Reviews Immunology.

[69]  C. Pesce,et al.  Overexpression of vascular endothelial growth factor and its endothelial cell receptor KDR in type 1 leprosy reaction. , 2002, The American journal of tropical medicine and hygiene.

[70]  A. Poggi,et al.  NK Cell Activation by Dendritic Cells Is Dependent on LFA-1-Mediated Induction of Calcium-Calmodulin Kinase II: Inhibition by HIV-1 Tat C-Terminal Domain1 , 2002, The Journal of Immunology.

[71]  T. Ahrens,et al.  Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. , 2001 .

[72]  R. Hartley,et al.  CD34− Blood‐Derived Human Endothelial Cell Progenitors , 2001, Stem cells.

[73]  P. Allavena,et al.  Dendritic cells as a major source of macrophage‐derived chemokine/CCL22 in vitro and in vivo , 2001, European journal of immunology.

[74]  F. C. Lucibello,et al.  Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells. , 2001, European journal of cell biology.

[75]  M. Rubio,et al.  CD47 Engagement Inhibits Cytokine Production and Maturation of Human Dendritic Cells1 , 2000, The Journal of Immunology.

[76]  S. Rafii,et al.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.

[77]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[78]  D. Carbone,et al.  Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[79]  S. Goerdt,et al.  Other functions, other genes: alternative activation of antigen-presenting cells. , 1999, Immunity.

[80]  M. Karkkainen,et al.  Vascular endothelial growth factor receptor-3. , 1999, Current topics in microbiology and immunology.

[81]  R. Steinman,et al.  Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. , 1998, Science.

[82]  A. Enk,et al.  Production of functional IL‐18 by different subtypes of murine and human dendritic cells (DC): DC‐derived IL‐18 enhances IL‐12‐dependent Th1 development , 1998, European journal of immunology.

[83]  A. Poggi,et al.  CD14+ CD34+ peripheral blood mononuclear cells migrate across endothelium and give rise to immunostimulatory dendritic cells. , 1998, Journal of immunology.

[84]  C Caux,et al.  The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. , 1998, Journal of immunology.

[85]  M. Kennedy,et al.  A common precursor for hematopoietic and endothelial cells. , 1998, Development.

[86]  V. Verhasselt,et al.  Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. , 1997, Journal of immunology.

[87]  D. Carbone,et al.  Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells , 1996, Nature Medicine.

[88]  A. Lanzavecchia,et al.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.

[89]  A. Mantovani,et al.  Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. , 1996, Blood.

[90]  W. Kamps,et al.  THE PRESENCE OF CYTOKINES IN LANGERHANS' CELL HISTIOCYTOSIS , 1996, The Journal of pathology.

[91]  J. Banchereau,et al.  Activation of human dendritic cells through CD40 cross-linking , 1994, The Journal of experimental medicine.

[92]  D. Palmer,et al.  Human immunodeficiency virus. , 1990, Journal of the American Podiatric Medical Association.